Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23 GBX | -2.13% | -16.67% | -8.73% |
02-29 | Oncimmune Holdings plc Provides Earnings Guidance for the Year 2024 | CI |
02-29 | Oncimmune Holdings plc Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
Business Summary
Number of employees: 52
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
ImmunoINSIGHTS
100.0
%
| 2 | 60.8 % | 1 | 100.0 % | -37.47% |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Rest of the World
93.1
%
| 1 | 21.4 % | 1 | 93.1 % | +65.64% |
Europe
6.9
%
| 1 | 19.8 % | 0 | 6.9 % | -86.67% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 31/07/23 | |
Martin Hudson
DFI | Director of Finance/CFO | - | 03/09/23 |
James R. Jett
CTO | Chief Tech/Sci/R&D Officer | - | 31/10/15 |
Tariq Sethi
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/19 |
Ron Kirschner
COO | Chief Operating Officer | - | 19/04/20 |
Cléa Rosenfeld
IRC | Investor Relations Contact | - | 30/06/19 |
Matthew Luttrell
PRN | Corporate Officer/Principal | - | 30/09/19 |
Cameron Barnard
PRN | Corporate Officer/Principal | - | 31/07/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Goold
BRD | Director/Board Member | 52 | 12/01/23 |
Timothy Bunting
BRD | Director/Board Member | 61 | 08/10/15 |
Ron Kirschner
COO | Chief Operating Officer | - | 19/04/20 |
Chief Executive Officer | 57 | 31/07/23 | |
Director/Board Member | - | 11/10/23 | |
Chairman | 54 | 07/07/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 74,142,147 | 52,785,507 ( 71.20 %) | 0 | 71.20 % |
Company contact information
Sector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.73% | 21.23M | |
+5.31% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B | |
+3.90% | 1.65B |
- Stock Market
- Equities
- ONC Stock
- Company Oncimmune Holdings plc